Please use this identifier to cite or link to this item:
Title: Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trial
Author: Sanches, Clara
Levy, Richard
Benisty, Sarah
Volpe-Gillot, Lisette
Habert, Marie-Odile
Kas, Aurelie
Ströer, Sébastian
Pyatigorskaya, Nadya
Kaglik, Anna
Bourbon, Angelina
Dubois, Bruno
Migliaccio, Raffaella
Valero Cabré, Antoni
Teichmann, Marc
Others: Universitat Oberta de Catalunya (UOC)
Sorbonne Université
Boston University School of Medicine
Keywords: Non-invasive brain stimulation
Transcranial direct current stimulation
Semantic dementia
Primary progressive aphasia
Language impairments
Neurodegenerative diseases
Issue Date: 20-Nov-2019
Publisher: Trials
Citation: Sanches, C., Levy, R., Benisty, S., Volpe-Gillot, L., Habert, M.-O., Kas, A., Ströer, S., Pyatigorskaya, N., Kaglik, A., Bourbon, A., Dubois, B., Migliaccio, R., Valero-Cabré, A. & Teichmann, M. (2019). Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: A double blind, sham controlled, randomized clinical trial. Trials, 20(), -. doi: 10.1186/s13063-019-3613-z
Also see:
Abstract: Background: Semantic dementia is a neurodegenerative disease that primarily affects the left anterior temporal lobe, resulting in a gradual loss of conceptual knowledge. There is currently no validated treatment. Transcranial stimulation has provided evidence for long-lasting language effects presumably linked to stimulation-induced neuroplasticity in post-stroke aphasia. However, studies evaluating its effects in neurodegenerative diseases such as semantic dementia are still rare and evidence from double-blind, prospective, therapeutic trials is required. Objective: The primary objective of the present clinical trial (STIM-SD) is to evaluate the therapeutic efficacy of a multiday transcranial direct current stimulation (tDCS) regime on language impairment in patients with semantic dementia. The study also explores the time course of potential tDCS-driven improvements and uses imaging biomarkers that could reflect stimulation-induced neuroplasticity. Methods: This is a double-blind, sham-controlled, randomized study using transcranial Direct Current Stimulation (tDCS) applied daily for 10 days, and language/semantic and imaging assessments at four time points: baseline, 3 days, 2 weeks and 4 months after 10 stimulation sessions. Language/semantic assessments will be carried out at these same 4 time points. Fluorodeoxyglucose positron emission tomography (FDG-PET), resting-state functional magnetic resonance imaging (rs-fMRI), T1-weighted images and white matter diffusion tensor imaging (DTI) will be applied at baseline and at the 2-week time point. According to the principle of inter-hemispheric inhibition between left (language-related) and right homotopic regions we will use two stimulation modalities - left-anodal and right-cathodal tDCS over the anterior temporal lobes. Accordingly, the patient population (n = 60) will be subdivided into three subgroups: left-anodal tDCS (n = 20), right-cathodal tDCS (n = 20) and sham tDCS (n = 20). The stimulation will be sustained for 20 min at an intensity of 1.59 mA. It will be delivered through 25cm2-round stimulation electrodes (current density of 0.06 mA/cm2) placed over the left and right anterior temporal lobes for anodal and cathodal stimulation, respectively. A group of healthy participants (n = 20) matched by age, gender and education will also be recruited and tested to provide normative values for the language/semantic tasks and imaging measures. Discussion: The aim of this study is to assess the efficacy of tDCS for language/semantic disorders in semantic dementia. A potential treatment would be easily applicable, inexpensive, and renewable when therapeutic effects disappear due to disease progression.
Language: English
ISSN: 1745-6215MIAR
Appears in Collections:Articles
Articles cientÍfics

Files in This Item:
File Description SizeFormat 
Valero-Cabre_Trial_transcranial.pdf3,76 MBAdobe PDFThumbnail